open access

Vol 1, No 4 (2012)
Pharmaceutical news
Published online: 2012-11-27
Get Citation

Acarbose – the new look

Jacek Sieradzki
Diabetologia Kliniczna 2012;1(4):159-164.

open access

Vol 1, No 4 (2012)
Pharmaceutical news
Published online: 2012-11-27

Abstract

The structure and mechanism of action of acarbose as well as ist role in normalization of postprandial hiperglycaemia is described. Acarbose is very important drug in reduction of risk of development of overt diabetes and in reduction of cardiovascular risk among persons with prediabetes state. The action as well as character of additional effects of acarbose is very similar to its described by incretins. Perhaps the mechanism of action of acarbose is partially  connected with its effect on intestine-pancreatic axis. The beneficients of acarbose are patients with type 2 diabetes with high postprandial glycaemia as well persons with prediabetes. In summary, acarbose can be prescribed in every stage of treatment of  type 2 diabetes.

Abstract

The structure and mechanism of action of acarbose as well as ist role in normalization of postprandial hiperglycaemia is described. Acarbose is very important drug in reduction of risk of development of overt diabetes and in reduction of cardiovascular risk among persons with prediabetes state. The action as well as character of additional effects of acarbose is very similar to its described by incretins. Perhaps the mechanism of action of acarbose is partially  connected with its effect on intestine-pancreatic axis. The beneficients of acarbose are patients with type 2 diabetes with high postprandial glycaemia as well persons with prediabetes. In summary, acarbose can be prescribed in every stage of treatment of  type 2 diabetes.

Get Citation

Keywords

alfa-glucosidase inhibitors; acarbose

About this article
Title

Acarbose – the new look

Journal

Clinical Diabetology

Issue

Vol 1, No 4 (2012)

Pages

159-164

Published online

2012-11-27

Bibliographic record

Diabetologia Kliniczna 2012;1(4):159-164.

Keywords

alfa-glucosidase inhibitors
acarbose

Authors

Jacek Sieradzki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl